Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association
Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinolo...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2023-01-01
|
Series: | European Thyroid Journal |
Subjects: | |
Online Access: | https://etj.bioscientifica.com/view/journals/etj/11/6/ETJ-22-0189.xml |
_version_ | 1828064822795698176 |
---|---|
author | Henry B Burch Petros Perros Tomasz Bednarczuk David S Cooper Peter J Dolman Angela M Leung Ilse Mombaerts Mario Salvi Marius N Stan |
author_facet | Henry B Burch Petros Perros Tomasz Bednarczuk David S Cooper Peter J Dolman Angela M Leung Ilse Mombaerts Mario Salvi Marius N Stan |
author_sort | Henry B Burch |
collection | DOAJ |
description | Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinologists. Endocrinologists, therefore, have a key role in diagnosis, initial management, and selection of patients who require referral to specialist care. Given that the need for guidance to endocrinologists charged with meeting the needs of patients with TED transcends national borders, and to maximize an international exchange of knowledge and practices, the American Thyroid Association and European Thyroid Association joined forces to produce this Consensus Statement. |
first_indexed | 2024-04-10T23:04:37Z |
format | Article |
id | doaj.art-76691c55701645b19f76590849948f3d |
institution | Directory Open Access Journal |
issn | 2235-0802 |
language | English |
last_indexed | 2024-04-10T23:04:37Z |
publishDate | 2023-01-01 |
publisher | Bioscientifica |
record_format | Article |
series | European Thyroid Journal |
spelling | doaj.art-76691c55701645b19f76590849948f3d2023-01-13T12:54:55ZengBioscientificaEuropean Thyroid Journal2235-08022023-01-01116137https://doi.org/10.1530/ETJ-22-0189Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid AssociationHenry B Burch0Petros Perros1Tomasz Bednarczuk2David S Cooper3Peter J Dolman4Angela M Leung5Ilse Mombaerts6Mario Salvi7Marius N Stan8National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA; Endocrinology Division, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA Department of Endocrinology, Leazes Wing, Royal Victoria Infirmary, Newcastle upon Tyne, United KingdomDepartment of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, PolandDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USADepartment of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, CanadaDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, UCLA David Geffen School of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California, USADepartment of Ophthalmology, University Hospitals Leuven, Leuven, BelgiumDepartment of Clinical and Community Services, Graves’ Orbitopathy Center, Endocrinology, Fondazione IRCCS Cà Granda, Milan, ItalyDivision of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, Minnesota, USAThyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinologists. Endocrinologists, therefore, have a key role in diagnosis, initial management, and selection of patients who require referral to specialist care. Given that the need for guidance to endocrinologists charged with meeting the needs of patients with TED transcends national borders, and to maximize an international exchange of knowledge and practices, the American Thyroid Association and European Thyroid Association joined forces to produce this Consensus Statement.https://etj.bioscientifica.com/view/journals/etj/11/6/ETJ-22-0189.xmlthyroid eye diseaseconsensus statementamerican thyroid associationeuropean thyroid association |
spellingShingle | Henry B Burch Petros Perros Tomasz Bednarczuk David S Cooper Peter J Dolman Angela M Leung Ilse Mombaerts Mario Salvi Marius N Stan Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association European Thyroid Journal thyroid eye disease consensus statement american thyroid association european thyroid association |
title | Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association |
title_full | Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association |
title_fullStr | Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association |
title_full_unstemmed | Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association |
title_short | Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association |
title_sort | management of thyroid eye disease a consensus statement by the american thyroid association and the european thyroid association |
topic | thyroid eye disease consensus statement american thyroid association european thyroid association |
url | https://etj.bioscientifica.com/view/journals/etj/11/6/ETJ-22-0189.xml |
work_keys_str_mv | AT henrybburch managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation AT petrosperros managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation AT tomaszbednarczuk managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation AT davidscooper managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation AT peterjdolman managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation AT angelamleung managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation AT ilsemombaerts managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation AT mariosalvi managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation AT mariusnstan managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation |